C8 β-D-galactosyl ceramide
| Catalog Number | BL-M001058 |
| CAS Number | 41613-16-5 |
| Description | C8 β-D-Galactosyl Ceramide, a synthetic ceramide with promising immunomodulatory capabilities, presents itself as a versatile tool for investigating the intricate interplay between inflammation, cancer, and autoimmune disorders in research settings. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]octanamide |
| Synonyms | C8 beta-D-galactosyl N-acylsphingosine; C8 Galactosyl(β) Ceramide (d18:1/8:0); beta-D-galactosyl-N-octanoylsphingosine; N-[(2S,3S,4E)-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-en-2-yl]octanamide |
| Molecular Weight | 587.83 |
| Molecular Formula | C32H61NO8 |
| Boiling Point | 783.4°C at 760 mmHg |
| Purity | >99% |
| Density | 1.1 g/cm3 |
| Solubility | Soluble in ethanol, methanol, and chloroform/methanol (9:1) |
| Appearance | White solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 65.38%, H 10.46%, N 2.38%, O 21.77% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCC)O |
| InChI | InChI=1S/C32H61NO8/c1-3-5-7-9-10-11-12-13-14-15-16-18-19-21-26(35)25(33-28(36)22-20-17-8-6-4-2)24-40-32-31(39)30(38)29(37)27(23-34)41-32/h19,21,25-27,29-32,34-35,37-39H,3-18,20,22-24H2,1-2H3,(H,33,36)/b21-19+/t25-,26+,27+,29-,30-,31+,32+/m0/s1 |
| InChI Key | LCEXEEHGNKGJES-SWMJIITPSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
